Applied Genetic Technologies Common Stock

Applied Genetic Technologies (AGTC) currently reports a common stock of $68K as of September 2022. That compares with $43K in the prior-year period — up 58.1% year over year. Use the charts on this page to explore Applied Genetic Technologies's common stock history and peer comparisons.

Applied Genetic Technologies's common stock increased from $43K to $68K — a 58.1% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Applied Genetic Technologies reported $68K in common stock as of September 2022. That compares with $43K in the prior-year period — up 58.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $68K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Applied Genetic Technologies, and consider following AGTC for alerts when major investors trade the stock.

Applied Genetic Technologies is classified in the Healthcare sector. On common stock, it currently shows $68K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGTC with unrelated industries.